genome interpretation Geneyx Genomex Closes $6.5M Seed Financing Round The Israeli-American startup develops AI-driven genetic data analysis and interpretation technology with an eye toward improving diagnostic yield. OncoDNA, Sophia Genetics Partner on Tumor Profiling OncoDNA will customize its OncoKDM platform to work with Sophia's DDM genomic analytics platform to help cancer centers adopt large-panel genomic profiling. Congenica Receives CE Mark for Clinical Decision Support Software With the CE-IVD designation, Congenica expects to apply its genomic data analysis and clinical decision support to the diagnosis of rare genetic disorders. Euformatics Expands to China With INSVAST Distribution Deal The Chinese next-generation sequencing bioinformatics distributor also sells secondary analysis products from Sentieon. Nostos Genomics Aims to Ease Variant Interpretation Bottlenecks With AI Premium The German bioinformatics startup recently partnered with Genomics England and Genomenon as it seeks to accelerate and bring transparency to genetic testing processes. Jun 1, 2021 Euformatics Expands Latin American Presence With A&C Group Distribution Deal May 10, 2021 Euformatics Signs Distribution Deal With Saudi Arabia's Al-Jeel Apr 19, 2021 Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Apr 13, 2021 Congenica Strikes Asian Distribution Deal With Camtech Diagnostics Apr 12, 2021 Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation Apr 6, 2021 Euformatics Eyes Global Expansion in NGS Informatics Premium Mar 26, 2021 Rare Disease Screening Firm 3billion Closes $13M Series C Financing Mar 18, 2021 Euformatics Partners With Síntese Biotecnologia to Enter Latin American Market Feb 23, 2021 BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research Feb 19, 2021 Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Dec 16, 2020 Illumina, Emedgene Partner on Automated Genomic Data Interpretation Nov 13, 2020 With $50M in New Funding, Congenica Works on Platform Upgrades for Clinical Applications Premium Oct 27, 2020 OmniTier Introduces Appliance for Tertiary Next-Generation Sequencing Analysis Premium Oct 14, 2020 PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis Oct 12, 2020 Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics May 7, 2020 Informatics Startup Breakthrough Genomics Developing Coronavirus Susceptibility Assessment Premium May 5, 2020 PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market Mar 13, 2020 Tempus Closes $100M Series G Round Feb 27, 2020 Sophia Genetics to Provide Access to Genomic Analysis Platform to MGI Customers Load More Breaking News Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent Molecular Diagnostics Firm Mainz Biomed Prices $22.5M Follow-on Share Offering The Scan Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there. Nucleic Acids Research Papers on Viral Recombination, Pan-Cancer Mutations, SARS-CoV-2 Variability In Nucleic Acids Research this week: updated pipeline to detect viral recombination, mutational patterns in tumor samples, and more.